0000950123-15-006567.txt : 20150515 0000950123-15-006567.hdr.sgml : 20150515 20150515171934 ACCESSION NUMBER: 0000950123-15-006567 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150515 DATE AS OF CHANGE: 20150515 EFFECTIVENESS DATE: 20150515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SV Life Sciences Advisers, LLC CENTRAL INDEX KEY: 0001587143 IRS NUMBER: 861154144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16271 FILM NUMBER: 15870969 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001587143 XXXXXXXX 03-31-2015 03-31-2015 SV Life Sciences Advisers, LLC

One Boston Place 201 Washington Street, Suite 3900 Boston MA 02108

13F HOLDINGS REPORT 028-16271 Y The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Life Sciences Advisers, LLC, a Delaware limited liability company ("Advisers"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners" and together with SVLS IV LP, the "Fund IV Entities"), and International Life Sciences Fund III (LP1), L.P. ("ILSF LP1"), International Life Sciences Fund III Co-Investment, L.P. ("ILSF Co-Invest"), and International Life Sciences Fund III Strategic Partners, L.P. ("ILSF Strategic" and together with ILSF LP1 and ILSF Co-Invest, the "Fund III Entities"), which are each Delaware limited partnerships (the Fund IV Entities and the Fund III Entities together, the "Funds"), directly own certain security positions reported by Advisers, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. Certain of the security positions reported by Advisers are also being reported by SVLS IV GP and SVLSF IV, LLC. Each of SVLS IV GP, SVLSF IV, LLC and Advisers may be deemed to share voting power and control over the shares held by the Fund IV Entities. Advisers may be deemed to share voting power and control over the shares held by the Fund III Entities. Each of SVLS IV GP, SVLSF IV, LLC and Advisers disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein. Denise W. Marks (617) 367-8100 /s/ Denise W. Marks Boston MA 05-15-2015 2 5 302636 false 1 028-16272 SVLSF IV, LLC 2 028-16273 SV Life Sciences Fund IV (GP), L.P. INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F OPHTHOTECH CORP COM 683745103 83703 1798906 SH OTR 1,2 0 1798906 0 OPHTHOTECH CORP COM 683745103 11830 254237 SH SOLE 254237 0 0 TRANSENTERIX INC COM NEW 89366M201 22112 7546692 SH OTR 1,2 0 7546692 0 OCULAR THERAPEUTIX INC COM 67576A100 108570 2585607 SH OTR 1,2 0 2585607 0 ENTELLUS MED INC COM 29363K105 76421 3489533 SH OTR 1,2 0 3489533 0